Sean P. Arlauckas

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy

Christopher B. Rodell, Sean P. Arlauckas, Michael F. Cuccarese et al. · Nature Biomedical Engineering · 2018 · 1.1K citations

Medicine, Immunology, Oncology +16

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler et al. · Immunity · 2018 · 937 citations · Full text

Medicine, Immunology, Oncology +12

In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

Sean P. Arlauckas, Christopher Garris, Rainer H. Köhler et al. · Science Translational Medicine · 2017 · 653 citations · Full text

Life Sciences, Immunology, Oncology +17

IRF3 and type I interferons fuel a fatal response to myocardial infarction

Kevin R. King, Aaron D. Aguirre, Yuxiang Ye et al. · Nature Medicine · 2017 · 569 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages

Sean P. Arlauckas, Seth B. Garren, Chris S Garris et al. · Theranostics · 2018 · 339 citations · Full text

Medicine, Immunology, Oncology +17